HOME >> BIOLOGY >> NEWS
Hydroxyurea therapy improves survival in most severely affected sickle cell patients

the treatment of sickle cell anemia. "Presently only a minority of eligible patients are taking hydroxyurea. Our study strongly suggests that adults with sickle cell anemia and clinically significant complications of their disease, like frequent painful episodes and the common pneumonia-like events, should take hydroxyurea under the supervision of a knowledgeable physician," Steinberg said.

"Most people who take this medication will feel better; we now know they will live longer," Steinberg added. Patients in the study will be followed for an additional 5 years, noted Bonds, who also added that hydroxyurea studies in children are planned.

Sickle cell anemia is an inherited disease that is most common among people whose ancestors come from Africa, the Middle East, the Mediterranean basin, and India. In the U.S., it affects primarily African Americans, about 72,000 of whom have the disease. One in 12 African Americans carries the sickle cell trait.

In patients with the disease, molecules of sickle hemoglobin stick to one another, forming long rods inside red blood cells and causing these cells to take on a sickle shape and become rigid. The sickled red cells are unable to squeeze through tiny blood vessels, depriving tissue of an adequate blood supply and causing painful episodes.


'"/>

Contact: NHLBI Communications Office
301-496-4236
NIH/National Heart, Lung, and Blood Institute
1-Apr-2003


Page: 1 2 3

Related biology news :

1. Targeted therapy knocks out pediatric brain cancer in mice
2. New anti-inflammatory strategy for cancer therapy identified by UCSD researchers
3. Columbia research to examine gene influence on severity of peridontal disease, therapy response
4. Case for IBD combination therapy comes from research at Baylor, MIT and Hebrew University
5. The search for a kinder, gentler chemotherapy
6. Embryonic stem cell therapy shows steady benefits in rebuilding infarcted heart
7. Retroviral gene therapy? ASLV, HIV, and MLV show distinct target site preferences
8. Gene changes linked to increased eye pressure may have implications for glaucoma therapy
9. Jefferson Lab detector technology aids development of cystic fibrosis therapy
10. Stroking up cellular therapy
11. Smart gene therapy protects against damage from heart attack

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/8/2019)... N.C. (PRWEB) , ... January 07, 2019 , ... ... and micro mechanical technologies and solutions for hearing instruments and specialty earphones, and ... BiometRIC, the first ever hearing aid receiver in canal with an embedded biometric ...
(Date:1/7/2019)... ... January 07, 2019 , ... ... leading supplier of Graph Database technology for Knowledge Graphs solutions, announced that it ... 2019 ‘Trend-Setting’ Product . DBTA’s data and information management recognition list includes ...
(Date:1/4/2019)... WORTH, Texas (PRWEB) , ... January 02, 2019 ... ... catalog. This release is particularly noteworthy, as the life science tools and service ... history, it is offering a catalog. The catalog features not just part numbers ...
Breaking Biology News(10 mins):
(Date:12/13/2018)... ... December 13, 2018 , ... ... includes food (human) ingredient. This has been part of their strategic plan and ... Plan and certification creates custom fermentation opportunities for MDG within the $44 Billion ...
(Date:12/5/2018)... ... December 05, 2018 , ... STRmix™ – sophisticated forensic software capable of resolving ... used to convict a Wyoming man of third-degree sexual assault, a felony punishable by ... test for DNA on the couch cushions on which the sexual assault was alleged ...
(Date:11/27/2018)... ... November 27, 2018 , ... New patients in need ... Dan Myers’ practice for treatment, with or without a referral. Dr. Myers has many ... including porcelain veneers, dental implants, bridges and custom crowns. , As a dedicated ...
(Date:11/20/2018)... ... November 20, 2018 , ... Each year Forbes receives thousands of nominations ... highlights outstanding performance by individuals under 30 years of age. The Forbes 30 Under ... Sports and Entertainment to Venture Capital and Science. , In 2017, Visikol CEO ...
Breaking Biology Technology:
Cached News: